P3 Health Partners (NASDAQ:PIII) Stock Price Up 29.1% – Here’s Why

P3 Health Partners Inc. (NASDAQ:PIII) shares shot up 29.1% during trading on Monday . The stock traded as high as $2.96 and last traded at $2.88. 198,749 shares were traded during trading, an increase of 748% from the average session volume of 23,427 shares. The stock had previously closed at $2.23.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on PIII. BTIG Research reissued a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. Lake Street Capital cut their price objective on P3 Health Partners from $20.00 to $12.50 and set a “buy” rating on the stock in a research note on Monday, November 17th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $12.50.

P3 Health Partners Price Performance

The firm has a market cap of $20.76 million, a P/E ratio of -0.07 and a beta of 0.86. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 2.29. The business’s 50 day moving average is $2.58 and its two-hundred day moving average is $5.67.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in P3 Health Partners stock. Trinity Financial Advisors LLC grew its holdings in P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,678 shares of the company’s stock after purchasing an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned about 0.37% of P3 Health Partners worth $239,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.